Splenic flexure cancer is a type of colon cancer that starts near the bend where the colon crosses the upper left side of the abdomen. Early symptoms of splenic flexure cancer can include belly pain, bloating, constipation, blood in the stool, tiredness, and weight loss, but some people have few symptoms at first. It is most often diagnosed in older adults, and it usually develops over time rather than appearing suddenly. Not everyone will have the same experience, and the outlook with splenic flexure cancer depends a lot on how far it has spread when it is found. Treatment often includes surgery, and some people also need chemotherapy, targeted therapy, or other cancer care.
How many people live with Splenic flexure cancer?
Splenic flexure cancer is usually counted inside the larger group of colon and rectal cancers, not as its own separate total: about 5.0 million people worldwide were living with colorectal cancer within 5 years of diagnosis (Global Cancer Observatory, 2022), so if cancers at the splenic flexure make up roughly 2% to 8% of these cases, that suggests about 100,000 to 400,000 people worldwide are living with it; this is an estimate, not a direct count, and the range is wide because studies do not all count this part of the colon in the same way. In the United States, about 1.5 million people were living with colon or rectal cancer (National Cancer Institute SEER, 2021), which suggests roughly 30,000 to 120,000 people may be living with splenic flexure cancer, again as an estimate rather than a direct count.
Overview
Splenic flexure cancerSymptoms
Splenic flexure cancer may cause belly pain, bloating, changes in bowel habits, blood in the stool, or tiredness from anemia. Early symptoms of splenic flexure cancer can be vague, and some people have no symptoms at first.
Outlook and prognosis
For people with splenic flexure cancer, outlook depends mainly on the stage, whether nearby lymph nodes are involved, and whether surgery can remove the tumor completely. Earlier-stage disease often has a better prognosis than cancer that has spread.
Causes and risk factors
Splenic flexure cancer risk rises with older age, inherited bowel cancer syndromes, inflammatory bowel disease, and a personal or family history of colorectal polyps or cancer. Smoking, heavy alcohol use, obesity, low activity, and diets high in processed or red meat may also raise risk.
Genetic influences
Genetics can be important in splenic flexure cancer. In some people, inherited conditions such as Lynch syndrome raise risk, and gene changes in the tumor can help guide treatment decisions.
Diagnosis
Splenic flexure cancer is usually diagnosed after symptoms or screening lead to colonoscopy with a biopsy. CT scans often help show the tumor and check whether it has spread.
Treatment and drugs
Treatment for splenic flexure cancer often starts with surgery to remove the tumor and nearby lymph nodes. Many also need chemotherapy, especially if the cancer has spread or might return. Some may receive targeted drugs or immunotherapy, depending on tumor testing.
Symptoms
Splenic flexure cancer can show up as stubborn bowel changes, belly pain, bloating, or blood in the stool, and many people first notice that everyday bathroom routines no longer feel normal. Because this part of the colon sits near the upper left side of the abdomen, discomfort can sometimes be felt there, though symptoms are not always easy to pinpoint. Symptoms vary from person to person and can change over time. Some people have only mild problems at first, while others develop signs of a bowel blockage more quickly.
Constipation, diarrhea, or going back and forth between the two can happen when stool has trouble moving through the colon. Changes in stool shape, such as narrower stools, can be among the early symptoms of splenic flexure cancer.
Cramping or aching pain may come and go, often after eating or before a bowel movement. Many living with splenic flexure cancer feel this in the left upper or middle part of the belly, but it can spread more widely.
A feeling of pressure, trapped gas, or fullness can build up as the bowel slows down. Day to day, it can feel like meals sit heavily or clothes feel tighter across the abdomen.
Stool may look bright red, dark red, or almost black if blood is mixed in. Sometimes the bleeding is small and not obvious, but it can still lead to other symptoms over time.
How people usually first notice Splenic flexure cancer?
Splenic flexure cancer often comes to attention quietly at first, when changes in the bowel no longer feel like a passing upset but start to linger: constipation, diarrhea, a sense that the bowel does not empty fully, or crampy pain and bloating high on the left side of the abdomen. Many people with splenic flexure cancer first notice blood in the stool, stools that look darker than usual, unusual tiredness from slow blood loss, or belly swelling if the tumor begins to narrow the colon and trap gas and stool. Because these symptoms can overlap with far more common digestive problems, the key warning sign is that they persist, worsen, or come with weight loss, weakness, or repeated episodes of severe abdominal pain.
Types of Splenic flexure cancer
Splenic flexure cancer can affect day-to-day life in different ways, from changes in bowel habits to tiredness that seems out of proportion to your routine. Symptoms don’t always look the same for everyone. Because this cancer sits in a bend of the colon, early symptoms of splenic flexure cancer can be easy to miss at first and may overlap with common digestive problems. Doctors sometimes classify symptoms as local bowel symptoms versus whole-body effects, with urgent blockage symptoms treated as a separate pattern.
Bowel changes
Many people with splenic flexure cancer notice constipation, diarrhea, or a change in how often they need to go. Some may feel that the bowel does not empty fully, or that stools have become narrower than usual.
Belly discomfort
Cramping, bloating, or pain under the upper left side of the abdomen can happen as stool and gas move less easily through this part of the colon. One person might mainly feel pressure after meals, while another notices off-and-on pain that builds over time.
Bleeding anemia
Some people with splenic flexure cancer lose small amounts of blood in the stool that are not always obvious. Over time, this can lead to anemia, which often causes fatigue, weakness, shortness of breath, or feeling lightheaded.
Blockage symptoms
Because the splenic flexure is a narrow turn in the bowel, some tumors are more likely to cause a partial or full blockage. This can lead to severe cramping, a swollen abdomen, vomiting, and trouble passing stool or gas, which needs urgent medical attention.
General effects
As the cancer grows, many living with splenic flexure cancer may have unplanned weight loss, low appetite, or a general sense of not feeling well. The balance of symptoms can shift over time, with some people noticing vague tiredness first and others developing more obvious bowel problems.
Can I slow down the onset of symptoms?
Not really—there is no proven way to meaningfully delay the start of symptoms from splenic flexure cancer, a type of colon cancer, once it is developing. What can help is lowering the chance of colon cancer overall: staying active, keeping a healthy weight, not smoking, limiting alcohol, and eating more fiber while cutting back on red and processed meat are linked to lower risk, but they do not guarantee prevention. The best-established medical step is regular colon cancer screening, such as stool tests or colonoscopy, which can find growths or cancer early, sometimes before symptoms begin, so healthy habits and screening are still worth doing even though they cannot promise a certain outcome.
What genetics can tell you about symptoms
Genetics can sometimes explain why splenic flexure cancer develops earlier than usual or runs in a family, especially in inherited conditions such as Lynch syndrome or familial adenomatous polyposis, and these can raise the chance of getting colorectal cancers at a younger age. Even so, the symptoms themselves, like belly pain, bloating, constipation, blood in the stool, or tiredness from anemia, are usually driven more by where the tumor is, how large it is, and whether it is causing blockage or bleeding than by a specific gene change. In short, genetic testing may help estimate risk, age of onset, and sometimes how the cancer may behave, but it usually cannot predict exactly which symptoms someone will have.
Causes and risk factors
Splenic flexure cancer usually starts when DNA changes build up in cells in this part of the colon over many years. The risk factors for splenic flexure cancer include older age, colon polyps, inflammatory bowel disease, and type 2 diabetes. Family history and inherited conditions such as Lynch syndrome can also raise risk. Smoking, heavy alcohol use, extra body weight, little exercise, and a diet high in red or processed meat may add to that risk. It is rarely just one factor, and the mix matters.
What are the most common causes or risk factors?
Splenic flexure cancer, a colon cancer that starts near the upper left bend of the large bowel, usually does not have one single cause, but it often begins when small growths in the bowel lining slowly change into cancer over many years. The strongest risk factors are older age, a personal or family history of colon polyps or colon cancer, inherited conditions that greatly raise the chance of colon cancer, and long-term inflammation in the bowel, such as ulcerative colitis or Crohn's disease. Smoking, heavy alcohol use, obesity, low physical activity, and a diet high in red or processed meat and low in fiber can also raise the risk.
Environmental and biological risk factors
Splenic flexure cancer often develops quietly, with risk building over many years before any warning signs appear. Many of these factors are present long before early symptoms of splenic flexure cancer show up. Doctors often group risks into internal (biological) and external (environmental).
The risk of colon cancers, including splenic flexure cancer, rises with age. This is partly because abnormal cell changes have more time to build up over the years.
Certain colon polyps, especially adenomatous or serrated polyps, can slowly turn into cancer if they are not found and removed. A personal history of these growths raises the chance of splenic flexure cancer later on.
If someone has already had colon or rectal cancer, the risk of another colorectal cancer is higher. This may reflect a bowel lining that has already shown a tendency to develop abnormal cells.
Long-standing ulcerative colitis or Crohn disease affecting the colon can increase risk. Ongoing inflammation can damage the bowel lining over time and make cancerous changes more likely.
Genetic risk factors
For many families, concern about splenic flexure cancer begins when colon cancer or large numbers of polyps seem to run in the family, especially at younger ages. Some risk factors are inherited through our genes. The main genetic risk factors for splenic flexure cancer are the same ones linked to colorectal cancer overall, particularly conditions that lead to many polyps or make it harder for cells to repair DNA mistakes. Most cases are not caused by one known inherited syndrome, but family patterns can still matter.
Family history: Having a parent, sibling, or child with colorectal cancer or advanced colon polyps can raise the chance of splenic flexure cancer. Risk is often higher when more than one close relative is affected or when cancer showed up before age 50. This pattern can point to an inherited cancer tendency even if no specific gene change has been identified.
Lynch syndrome: Lynch syndrome is the most common inherited cause of colorectal cancer and can also raise the risk of splenic flexure cancer. It happens when a gene that normally repairs DNA copying mistakes does not work well. Families may also have more uterine, ovarian, stomach, small bowel, pancreatic, or urinary tract cancers.
FAP: Familial adenomatous polyposis, or FAP, causes many colon polyps, often starting in the teen years or early adulthood. Without treatment, the lifetime risk of colorectal cancer is very high. Cancer can develop in any part of the colon, including the splenic flexure.
MUTYH polyposis: MUTYH-associated polyposis is a rarer inherited condition that can cause multiple polyps and increase colorectal cancer risk. It usually happens when both copies of the MUTYH gene are not working, one inherited from each parent. Some people have only a small number of polyps, so the condition may be easy to miss.
Peutz-Jeghers: Peutz-Jeghers syndrome causes polyps in the digestive tract and raises the risk of several cancers, including colorectal cancer. Some families also notice dark freckle-like spots around the lips, mouth, or fingers. This inherited condition can increase the chance of a tumor forming near the splenic flexure as part of the overall colon cancer risk.
Juvenile polyposis: Juvenile polyposis syndrome causes multiple polyps in the digestive tract and raises colorectal cancer risk over time. Here, juvenile refers to the polyp type rather than the person's age. It often runs in families and may affect more than one generation.
Lifestyle risk factors
Several everyday habits can influence the chance of developing splenic flexure cancer, which is a form of colon cancer. Most of the same lifestyle patterns linked to colorectal cancer also apply here because the splenic flexure is part of the colon. Understanding lifestyle risk factors for splenic flexure cancer can help focus prevention on modifiable behaviors.
Frequent intake of processed meats such as bacon, sausage, and deli meats is linked to a higher colorectal cancer risk. Chemicals formed during processing and preservation can promote harmful changes in the colon over time.
Eating large amounts of red meat, especially when cooked at high temperatures, may raise risk. Grilling, charring, and frying can create compounds that damage cells lining the colon.
Diets low in whole grains, fruits, vegetables, and legumes may increase risk by slowing stool transit and reducing beneficial gut effects. Higher fiber intake is associated with a lower risk of colorectal cancer.
Regular heavy alcohol use increases the risk of colon and rectal cancers. Alcohol can damage DNA, affect folate metabolism, and increase exposure of colon tissue to carcinogenic byproducts.
Risk prevention
Splenic flexure cancer is a type of colon cancer, so many of the same prevention steps apply. No one can reduce the risk to zero, but there is a lot people can do to lower it. Prevention is about lowering risk, not eliminating it completely. For many people wondering how to lower the risk of splenic flexure cancer, the biggest steps are screening, not smoking, staying active, and supporting overall bowel health.
Regular colon cancer screening can find and remove polyps before they turn into splenic flexure cancer. Depending on your age, family history, and other risks, this may include stool tests, colonoscopy, or both.
A strong family history of colon cancer or inherited bowel cancer syndromes can raise the chance of splenic flexure cancer. If close relatives have had colon cancer or many polyps, genetic counseling and earlier screening may help.
Regular physical activity is linked to a lower risk of colon cancer, including splenic flexure cancer. Even brisk walking most days can help, especially if long sitting time is reduced.
Carrying excess body weight, especially around the abdomen, is linked to a higher risk of colon cancer. Reaching and keeping a healthy weight over time may help lower the chance of splenic flexure cancer.
Can you prevent Splenic flexure cancer?
You cannot fully prevent splenic flexure cancer, but you can often lower the risk because it is a type of colon cancer. The most proven steps are keeping up with colon cancer screening, not smoking, limiting alcohol, staying active, keeping a healthy weight, and eating a balanced diet with less processed and red meat. Even with these steps, some people still develop it, especially if they have a strong family history or certain bowel diseases.
Transmission
Splenic flexure cancer is not infectious, so you cannot catch it from someone through close contact, kissing, sex, sharing food, or simply being around them. For many, this is an important reassurance: even if a loved one has splenic flexure cancer, it cannot spread from one person to another.
If you are wondering how splenic flexure cancer is inherited, the cancer itself is usually not passed directly from parent to child, but a higher risk can be. Some families carry inherited gene changes that make colon cancer more likely, so a strong family history may matter, but most cases happen without a clear inherited pattern.
When to test your genes
Consider genetic testing if splenic flexure cancer is diagnosed at a young age, if you have relatives with colorectal, uterine, or related cancers, or if more than one colon cancer has occurred in the family. Tumor gene testing is also often used after diagnosis to guide treatment and check for Lynch syndrome.
Diagnosis
Splenic flexure cancer is often found after symptoms lead to testing, although some people learn about it during routine colorectal cancer screening. You might notice small changes in daily routines, such as needing the bathroom more often, seeing blood in the stool, or feeling more tired than usual. Doctors usually confirm the diagnosis of splenic flexure cancer with a colon exam and a tissue sample, then use scans to see whether it has spread.
Doctors ask about symptoms such as belly pain, changes in bowel habits, blood in the stool, weight loss, and tiredness. A detailed family and health history can help show whether colorectal cancer, polyps, or inherited cancer risk may be part of the picture.
A physical exam checks for signs such as abdominal tenderness, bloating, or weight loss. Doctors may also look for signs of anemia, which can happen when slow bleeding from the tumor goes unnoticed.
Blood tests can look for anemia, signs of blood loss, and liver problems that could suggest spread beyond the colon. A tumor marker called CEA may also be measured, although it cannot diagnose the cancer by itself.
Colonoscopy is the main test used to find splenic flexure cancer because it lets doctors see the inside of the colon directly. If an abnormal area is found, a small tissue sample is taken during the test so a lab can confirm whether cancer cells are present.
How is Splenic flexure cancer diagnosed?
Splenic flexure cancer, which is cancer in the bend of the large intestine near the spleen, is usually diagnosed with a colonoscopy, where a doctor uses a thin camera tube to look inside the colon and take a small tissue sample to check under a microscope. Doctors also often use scans such as a CT scan to see exactly where the cancer is and whether it has spread, and blood tests may help look for problems like anemia or signs of cancer activity. Genetic testing is not usually what first makes the diagnosis, but it may be offered later if the tumor has certain features or if there is a strong family history of colon cancer.
Stages of Splenic flexure cancer
Splenic flexure cancer is usually described in stages based on how far it has grown through the bowel wall and whether it has spread to lymph nodes or other parts of the body. Doctors usually start with a conversation about symptoms, then use scans, blood tests, and a colonoscopy with a biopsy to work out the stage. Many people feel relief once they understand what’s happening, because the stages of splenic flexure cancer help guide treatment choices and give a clearer sense of what comes next.
Stage 0
The cancer is only in the inner lining of the colon and has not grown deeper. This is the earliest stage and is often found during testing rather than from obvious symptoms.
Stage I
The cancer has grown into the deeper layers of the colon wall but has not spread outside the bowel. Treatment is often aimed at removing it completely with surgery.
Stage II
The cancer has grown through more of the colon wall and may reach nearby tissues, but it has not spread to lymph nodes. Some people are diagnosed at this stage after ongoing bowel changes, belly pain, or other early symptoms of splenic flexure cancer lead to testing.
Stage III
The cancer has spread to nearby lymph nodes but not to distant organs. Treatment usually includes surgery and often chemotherapy to lower the chance of the cancer coming back.
Stage IV
The cancer has spread to distant parts of the body, most often the liver, lungs, or lining of the abdomen. Care may still include surgery, but treatment often focuses on medicines and other therapies to control the cancer and ease symptoms.
Outlook and prognosis
Outlook for splenic flexure cancer depends mainly on the stage at diagnosis, whether the tumor can be completely removed, and the person’s overall health. When found early and treated with surgery, outcomes can be favorable, with survival similar to other colon cancers at the same stage. Prognosis is worse if the cancer has spread to lymph nodes or distant organs, or if complications such as bowel obstruction or perforation are present, which can delay treatment and increase risk. Because tumors at the splenic flexure can be harder to detect promptly and may present at a more advanced stage, some patients face a less favorable course than those with cancers found earlier elsewhere in the colon. Mortality varies widely by stage, with low death rates in localized disease after successful treatment and much higher mortality in metastatic disease. Ongoing follow-up is important, since recurrence risk is highest in the first few years after treatment.
Long-term effects
Long-term effects of splenic flexure cancer can come from the cancer itself, the surgery used to remove it, and treatments such as chemotherapy. Thinking about the long-term effects helps explain why some people feel well after treatment, while others continue to notice changes in digestion, energy, or overall health. The outlook for splenic flexure cancer varies widely and depends on the stage at diagnosis, whether it has spread, and how fully it responds to treatment.
Many people living with splenic flexure cancer notice lasting changes in bowel habits after treatment, including constipation, looser stools, cramping, or a stronger sense of urgency. These changes can happen because part of the colon has been removed or because the bowel is still adjusting after surgery.
Scar tissue or narrowing where the bowel was joined back together can sometimes lead to partial or complete blockage later on. This may cause bloating, pain, vomiting, or trouble passing stool and gas, and it may need urgent medical care.
One of the main long-term concerns is that splenic flexure cancer can come back in the colon, nearby lymph nodes, or other organs such as the liver or lungs. The risk is usually highest in the first few years after treatment, which is why doctors may track these changes over years to see whether the cancer stays under control.
Tiredness can last for months or longer, even after treatment has ended and scans look reassuring. For many, symptoms improve slowly, but some people continue to feel drained during work, exercise, or everyday tasks.
How is it to live with Splenic flexure cancer?
Living with splenic flexure cancer can affect daily life in both obvious and subtle ways, from abdominal pain, bloating, changes in bowel habits, and fatigue to the emotional strain of tests, treatment decisions, and waiting for results. Many people living with this cancer need to plan around medical visits, surgery, chemotherapy, or recovery time, and some may find that eating, working, exercise, and sleep become less predictable for a while. The effects often reach beyond the person with cancer, as family and friends may take on caregiving, transportation, household tasks, and emotional support, which can be meaningful but also tiring. Even so, with good symptom control, practical help, and a care team you trust, many people are able to keep important parts of daily life going during treatment.
Treatment and drugs
Splenic flexure cancer is usually treated with surgery first, because removing the tumor and nearby lymph nodes offers the best chance of control when this is possible. Depending on the stage, many people also need drug treatment such as chemotherapy, either after surgery to lower the chance of the cancer coming back or before surgery to shrink the tumor. If the cancer has spread, treatment may focus on slowing growth and easing symptoms, and some people may also receive targeted drugs or immunotherapy if testing shows the tumor has certain features. Treatment plans often combine several approaches, and your cancer team will tailor care to the size and spread of the cancer, your overall health, and day-to-day needs.
Can you cure Splenic flexure cancer?
Sometimes, splenic flexure cancer can be cured, especially if it is found early and removed with surgery before it has spread. If it has spread to other parts of the body, a cure is less likely, but treatment such as surgery and chemotherapy can often shrink the cancer, slow it down, and help people live longer with fewer symptoms.
Non-drug treatment
Daily life with splenic flexure cancer can involve changes in bowel habits, eating, energy, and planning around treatment. For many, treatment begins not at the pharmacy, but with procedures and supportive care that aim to remove the cancer, ease symptoms, and help you recover strength. The main non-drug treatments depend on the stage of splenic flexure cancer, your overall health, and whether the tumor is causing a blockage or bleeding. In some people, care also includes help with nutrition, activity, emotional support, and symptom relief before or after treatment.
Surgery is the main non-drug treatment for many people with splenic flexure cancer. It usually removes the section of colon containing the tumor along with nearby lymph nodes. Depending on the situation, the surgeon may reconnect the bowel or create a temporary or permanent ostomy.
If the tumor is blocking the bowel, a small mesh tube called a stent may be placed during a scope procedure to open the colon. This can quickly ease pain, bloating, constipation, and vomiting, and it may buy time before planned surgery.
Radiation is not routine for most colon cancers, but it may be used in selected cases to help control pain, bleeding, or local tumor growth. Not every approach works the same way, so whether it is useful depends on where the cancer has spread and your treatment goals.
Many living with splenic flexure cancer have trouble eating well because of poor appetite, nausea, early fullness, or fear of making symptoms worse. A dietitian can help with small frequent meals, protein-rich foods, fluids, and practical changes before surgery or during recovery.
Your genes may have an impact on how drugs work for you
For people with splenic flexure cancer, inherited gene differences and changes inside the cancer itself can affect which medicines are most likely to help and which may cause stronger side effects. For example, some people break down common chemotherapy drugs more slowly, which can raise the risk of severe diarrhea, mouth sores, or dangerously low blood counts, while certain cancer-cell changes can make some targeted treatments unlikely to work. Because of this, doctors often test the tumor, and sometimes a blood or saliva sample, before choosing treatment so care can be matched more safely and more closely to the person.
Pharmacological treatments
Drug treatment for splenic flexure cancer often depends on the stage of the cancer, whether surgery is planned or already done, and whether the cancer has spread. The medicines used are usually the same as those used for other colon cancers and may be given alone or in combination. In early-stage disease, treatment after surgery may lower the chance of the cancer coming back, while in advanced disease it may help slow growth and ease symptoms. Not everyone responds to the same medication in the same way.
Fluorouracil, often called 5-FU, is a core chemotherapy drug for splenic flexure cancer, and leucovorin is given with it to help 5-FU work better. It may be used after surgery or for cancer that has spread.
Capecitabine is an oral chemotherapy drug that turns into 5-FU in the body. Some people take it instead of IV 5-FU, either alone or with other medicines as part of chemotherapy for splenic flexure cancer.
Oxaliplatin is commonly paired with 5-FU and leucovorin in FOLFOX or with capecitabine in CAPOX. These combinations are often first-line treatment after surgery or for metastatic disease, though numbness or tingling in the hands and feet can become a limiting side effect.
Irinotecan is another chemotherapy drug, often used in combinations such as FOLFIRI. It is commonly used when oxaliplatin is not suitable or when the cancer grows after earlier treatment.
Genetic influences
When colon cancer shows up more than once in a family, it can bring up real questions about what may be inherited. It’s natural to ask whether family history plays a role. For most people with splenic flexure cancer, there is no single inherited cause, but genetics can still matter because some families carry gene changes that sharply raise the risk of colon cancer, especially in conditions such as Lynch syndrome or familial adenomatous polyposis. In many others, the gene changes linked to splenic flexure cancer happen only in the tumor over time and are not passed from parent to child. A strong family history, cancer at a younger age, or several relatives with colon, uterine, or related cancers can be clues that genetic counseling and testing may help clarify risk. This can be useful not only for the person with splenic flexure cancer, but also for relatives who may want to understand their own screening needs.
Is Splenic flexure cancer genetic?
Genetics can be important in splenic flexure cancer. In some people, inherited conditions such as Lynch syndrome raise risk, and gene changes in the tumor can help guide treatment decisions.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most of these variants do not directly affect health and are simply part of normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for splenic flexure cancer is often shaped by gene changes in the cancer itself, and sometimes by inherited gene differences in the person receiving care. Not every difference in response is genetic, but testing the tumor can show whether medicines such as immunotherapy or certain targeted drugs are more or less likely to help. For example, cancers with mismatch repair problems, often called dMMR or MSI-high, may respond well to immunotherapy, while cancers with changes in KRAS or NRAS usually do not benefit from anti-EGFR drugs such as cetuximab or panitumumab. A BRAF V600E change can open the door to a targeted drug combination, and a few tumors are checked for rarer changes such as HER2 or NTRK because those can also affect treatment choices. Your own genes can matter too: some people have inherited changes, such as in DPYD or UGT1A1, that make common chemotherapy drugs more likely to cause serious side effects or require a lower dose. That is why genetic testing for splenic flexure cancer treatment may include both tumor testing and, in some situations, blood testing, so doctors can choose safer and more effective therapy.
Interactions with other conditions
Splenic flexure cancer can be harder to spot because its symptoms may overlap with other bowel problems, such as diverticulitis, irritable bowel syndrome, or inflammatory bowel disease, so the early symptoms of splenic flexure cancer are sometimes mistaken for a more familiar gut issue. Many living with long-standing inflammatory bowel disease, especially when the colon has been inflamed for years, may have a higher chance of developing colon cancer, including cancer in the splenic flexure. Doctors call it a comorbidity when two conditions occur together. In day-to-day life, this can matter because anemia, heart disease, diabetes, or lung disease may make fatigue worse, raise the risks around surgery, or affect how well someone tolerates chemotherapy. Some may also find that constipation or partial bowel blockage from splenic flexure cancer becomes more serious when another digestive condition is already slowing the bowel. Because of this, it helps for the cancer team and any other specialists to coordinate care so treatment fits the whole picture, not just the tumor.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Splenic flexure cancer?
Symptoms of splenic flexure cancer, like belly pain, bloating, constipation, blood in the stool, or unexplained weight loss, can also happen with diverticulitis, irritable bowel syndrome, and inflammatory bowel disease such as Crohn's disease or ulcerative colitis. Bleeding or changes in bowel habits may also be caused by hemorrhoids or noncancerous colon polyps, which is why doctors often need tests to tell these conditions apart.
History
Changes in bowel habits, cramping high on the left side of the belly, or unexplained tiredness can be easy to brush off at first. For some people, those everyday problems turn out to be splenic flexure cancer, a cancer that develops in the bend of the colon near the spleen. Because this part of the bowel sits in a tucked-away corner of the abdomen, the condition was not always easy to recognize in earlier medicine.
Throughout history, people have described bowel problems that likely included cancers in different parts of the colon, but doctors could not clearly tell one location from another until anatomy and surgery became more precise. In the 1800s and early 1900s, as hospitals began keeping better records and autopsies became more detailed, physicians started separating colon cancers by where they arose. That mattered because tumors near the splenic flexure could behave differently from those in other parts of the colon and could be harder to reach during surgery.
As medical science evolved, X-rays with contrast, then colonoscopy, CT scans, and modern pathology made it much easier to spot cancers in this area and confirm exactly where they started. Earlier diagnosis also improved when screening for colorectal cancer became more common, since some people with early symptoms of splenic flexure cancer have only subtle warning signs at first. Over time, doctors also learned that cancers in this region may sometimes cause blockage sooner than tumors in roomier parts of the colon, simply because the passage can be narrower there.
Treatment has changed greatly over the past century. Early operations were riskier, and recovery was often long and difficult. Today, surgery is more standardized, imaging helps surgeons plan ahead, and chemotherapy and other treatments can be added when needed. Researchers later identified genetic and molecular factors that help explain why colon cancers differ from one another, although splenic flexure cancer is still usually discussed as part of the broader group of colon cancers rather than as a completely separate disease.
This history helps explain why splenic flexure cancer may sound unfamiliar even though colon cancer itself is common. What once seemed like a hard-to-define problem in a hidden part of the bowel is now better understood, easier to locate, and more treatable than in the past.